Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	microtubule	TTLL3 MAP1A FAM110A SPAG8 CEP170 SVIL RASSF3 PSRC1 KIF21A TOGARAM2 AKNA MAP7 RADIL SHROOM1 RACGAP1 RP1 SKA3	1.05e-05	533	194	17	GO:0005874
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 TRPM4 ABL1 PPRC1 ADGRB2 FAM110A SFI1 BIRC6 ABCA7 RNF43 MAPK8IP3 PRR12 TULP4 NAV2 MICAL3 UBE3B AKNA CHSY1 POM121C ATP13A2 TRAK1 PKMYT1 PIKFYVE RADIL ARHGEF40 LATS2 BTBD7 MARK4 HELZ2 STEAP3 DOT1L MAPKBP1 ZNF839	6.46e-15	1105	198	33	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ABL1 ARHGEF17 LUZP1 RUSC2 CEP170 CASKIN2 PRRC2C SVIL NAV2 WNK4 PML CARMIL2 BCAR1 MAP7 E2F8 TRAK1 RADIL LMO7 SIPA1L1 MARK4 RACGAP1 SKA3 SRRM2	9.75e-10	861	198	23	36931259
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SART3 DDAH1 MAP1A RPS6 WRNIP1 PSMD3 CHD3 ARHGEF17 JMY LUZP1 MAPK8IP3 CEP170 SLC24A2 PRRC2C SVIL MICAL3 PLPPR2 GOLGA3 CNTN1 IQSEC3 SGIP1 CARMIL2 ANK2 MAP7 LMO7 MICAL2 SIPA1L1 SLC4A10 RPL8	3.18e-09	1431	198	29	37142655
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MON2 ZFYVE16 PPRC1 ARHGEF17 RUSC2 PLEKHH1 PRRC2C MICAL3 IQSEC3 TRAK1 BTBD7 SIPA1L1 MARK4 MAPKBP1 SRRM2	1.47e-08	407	198	15	12693553
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MON2 BRPF3 MAP1A WRNIP1 CHD3 ABCA7 RNF43 LUZP1 DMAP1 CEP170 ZNF469 WWC1 PML TCOF1 ZC3H18 MAP7 POM121C EDEM3 ARHGEF40 PBRM1 SIPA1L1 MARK4 LRP2 SRRM2	2.73e-08	1116	198	24	31753913
Pubmed	Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.	STK11 PALB2 CHEK2	1.82e-07	3	198	3	20722467
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAP1A RAD54L2 TASOR2 ZNF469 TULP4 BUB1 WNK4 TCOF1 BCAR1 POM121C SH3D21 PRX INAVA GPRC5B	2.05e-07	430	198	14	35044719
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 MAP1A E2F7 RAD54L2 LUZP1 PRRC2C BUB1 PML TCOF1 ZC3H18 BCAR1 MAP7 TBC1D8 PIKFYVE LMO7 DOT1L	3.07e-07	588	198	16	38580884
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	MAP1A LUZP1 MICAL3 GOLGA3 WWC1 RC3H2 MAP7 TRAK1 TBC1D8 SIPA1L1	3.76e-07	209	198	10	36779422
Pubmed	The interactome of the histone gene regulatory factor HiNF-P suggests novel cell cycle related roles in transcriptional control and RNA processing.	PRRC2C MKI67 TTF2 POM121C SRRM2	6.04e-07	29	198	5	17577209
Pubmed	ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.	ATR PML CHEK2	7.24e-07	4	198	3	16891316
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1A RPS6 LUZP1 MAPK8IP3 IQSEC3 SGIP1 SIPA1L1 SLC4A10 SRRM2 RPL8	9.38e-07	231	198	10	16452087
Pubmed	Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR.	ATR PML CHEK2	1.80e-06	5	198	3	17030982
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	RPS6 PSMD3 BIRC6 PHKA1 CASKIN2 RC3H2 PIKFYVE LMO7 SIPA1L1 DOT1L	1.98e-06	251	198	10	29778605
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	ABL1 CASKIN2 PSRC1 MAP7 RACGAP1 SRRM2 DDX28	2.99e-06	108	198	7	19531213
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	MKI67 ALK TRIM41 MAP7 CDCA8 PKMYT1 RACGAP1 SKA3 SRRM2	3.60e-06	210	198	9	16565220
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SART3 ATR CHD3 RAD54L2 RUSC2 PRR12 CASKIN2 PRRC2C BUB1 MICAL3 RC3H2 UBE3B TGM2 ARHGEF40 RACGAP1	5.44e-06	650	198	15	38777146
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP1A MAPK8IP3 RUSC2 MICAL3 IQSEC3 SGIP1 ANK2 RADIL SIPA1L1 SLC4A10 SRRM2	5.49e-06	347	198	11	17114649
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	RPS6 WRNIP1 CEP170 SVIL GOLGA3 TCOF1 AKNA PIKFYVE PABPN1 SP6 SRRM2	6.46e-06	353	198	11	27545878
Pubmed	The Interleukin-2-mTORc1 Kinase Axis Defines the Signaling, Differentiation, and Metabolism of T Helper 1 and Follicular B Helper T Cells.	RPS6 E2F7 BUB1 MKI67 MUC20 CDCA8 E2F8 PKMYT1 RACGAP1	6.76e-06	227	198	9	26410627
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MON2 SART3 MAP1A RPS6 ADGRB2 WRNIP1 PSMD3 PLPPR3 BIRC6 MAPK8IP3 CEP170 PRRC2C PLPPR2 IQSEC3 SGIP1 ANK2 SIPA1L1 SLITRK5 SLC4A10 RPL8	9.02e-06	1139	198	20	36417873
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	PDCD2 BIRC6 LUZP1 CEP170 RASSF3 WWC1 TTF2 TRIM41 RADIL LATS2 LMO7 SIPA1L1	1.08e-05	446	198	12	24255178
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SART3 BRPF3 SFI1 GMEB2 DMAP1 CASKIN2 NAV2 CACNA1G KIF21A AKNA CHSY1 LMO7 RACGAP1	1.21e-05	529	198	13	14621295
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SART3 SELENOH CHD3 LUZP1 CEP170 BHLHA15 PRRC2C SVIL MKI67 ALK RC3H2 ANK2 TCOF1 ANKRD36B TGM2 ARHGEF40 PBRM1 LMO7 PABPN1 HELZ2 RACGAP1 DDX28	1.29e-05	1371	198	22	36244648
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	CARMIL3 PRR12 NAV2 MICAL3 GOLGA3 PSRC1 MUC20 POM121C SH3D21 TBC1D8 LMO7 HELZ2 TNXB	1.89e-05	552	198	13	10737800
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	MAP1A ZFYVE16 WRNIP1 CASKIN2 ALK BCAR1 PIKFYVE TGM2 SKA3 RPL8	2.01e-05	327	198	10	15592455
Pubmed	Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.	ATR PALB2 CHEK2	2.12e-05	10	198	3	37592023
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	SART3 CEP170 SVIL MKI67 PML POM121C PBRM1 HELZ2 RACGAP1 DDX28	2.28e-05	332	198	10	25693804
Pubmed	Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.	ATR BUB1 MKI67 CDCA8 EDN1	2.61e-05	61	198	5	27694478
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	ARHGEF17 BCAR1 LMO7 SIPA1L1 RACGAP1 SRRM2	2.70e-05	102	198	6	15778465
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SART3 PPRC1 RPS6 PSMD3 CHD3 RAD54L2 LUZP1 TASOR2 STK11 PRRC2C NAV2 ANK2 KIF21A KHDRBS2 JSRP1 SLC4A3 SH3D21 PALB2 PRX CCDC27 LATS2 LMO7	2.77e-05	1442	198	22	35575683
Pubmed	Pias1 is essential for erythroid and vascular development in the mouse embryo.	BMP2 MKI67 PML	2.90e-05	11	198	3	27155222
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	MON2 MYT1 MAPK8IP3 PRRC2C IQSEC3 TRAK1	3.01e-05	104	198	6	10470851
Pubmed	Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.	ABL1 BCAR1	3.22e-05	2	198	2	7780740
Pubmed	Medial epithelial seam cell migration during palatal fusion.	MKI67 EFNB2	3.22e-05	2	198	2	31264714
Pubmed	Opposing effects of bone morphogenetic protein-2 and endothelin-1 on lung fibroblast chloride currents.	BMP2 EDN1	3.22e-05	2	198	2	21659661
Pubmed	Atypical E2Fs inhibit tumor angiogenesis.	E2F7 E2F8	3.22e-05	2	198	2	28925392
Pubmed	Ankyrin-B directs membrane tethering of periaxin and is required for maintenance of lens fiber cell hexagonal shape and mechanics.	ANK2 PRX	3.22e-05	2	198	2	26538089
Pubmed	Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.	PALB2 CHEK2	3.22e-05	2	198	2	30613976
Pubmed	Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations.	PALB2 CHEK2	3.22e-05	2	198	2	38061684
Pubmed	An exome-first approach to aid in the diagnosis of primary ciliary dyskinesia.	GOLGA3 AKNA	3.22e-05	2	198	2	32367404
Pubmed	E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.	E2F7 E2F8	3.22e-05	2	198	2	32259305
Pubmed	Clinical utility of testing for PALB2 and CHEK2 c.1100delC in breast and ovarian cancer.	PALB2 CHEK2	3.22e-05	2	198	2	34113003
Pubmed	DNA-damage response control of E2F7 and E2F8.	E2F7 E2F8	3.22e-05	2	198	2	18202719
Pubmed	An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation.	RAD54L2 MKI67	3.22e-05	2	198	2	17374848
Pubmed	Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.	ATR CHEK2	3.22e-05	2	198	2	9857181
Pubmed	Genome-wide CRISPR screens in spheroid culture reveal that the tumor suppressor LKB1 inhibits growth via the PIKFYVE lipid kinase.	STK11 PIKFYVE	3.22e-05	2	198	2	38743625
Pubmed	Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.	MKI67 RACGAP1	3.22e-05	2	198	2	23096218
Pubmed	Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.	PML CHEK2	3.22e-05	2	198	2	16835227
Pubmed	RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma.	E2F7 RACGAP1	3.22e-05	2	198	2	26018753
Pubmed	E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7.	E2F7 E2F8	3.22e-05	2	198	2	15897886
Pubmed	KIF21A-mediated axonal transport and selective endocytosis underlie the polarized targeting of NCKX2.	SLC24A2 KIF21A	3.22e-05	2	198	2	22442075
Pubmed	Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.	E2F7 E2F8	3.22e-05	2	198	2	27452520
Pubmed	The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl.	ABL1 LATS2	3.22e-05	2	198	2	23852372
Pubmed	E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.	E2F7 E2F8	3.22e-05	2	198	2	22180533
Pubmed	Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.	PALB2 CHEK2	3.22e-05	2	198	2	31206626
Pubmed	Postnatal eye size in mice is controlled by SREBP2-mediated transcriptional repression of Lrp2 and Bmp2.	BMP2 LRP2	3.22e-05	2	198	2	35833708
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	ATR WRNIP1 PSMD3 CHD3 SFI1 BUB1 TTF2 KIF21A MAP7 LMO7 PABPN1 RACGAP1 SRRM2	3.26e-05	582	198	13	20467437
Pubmed	RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway.	RPS6 E2F7 RC3H2 MAP7 PABPN1 SRRM2 RPL8	3.32e-05	156	198	7	26170170
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ADGRB2 LUZP1 MAPK8IP3 CEP170 PRRC2C SVIL GOLGA3 CNTN1 VGF IQSEC3 SGIP1 ANK2 TCOF1 KIF21A PBRM1 SIPA1L1 RACGAP1	4.08e-05	963	198	17	28671696
Pubmed	Protein phosphatase 1α interacting proteins in the human brain.	CEP170 CLCN2 SH3RF2 CNTN1 PHACTR3	4.12e-05	67	198	5	22321011
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	CEP170 SVIL MICAL3 SGIP1 ANK2	4.12e-05	67	198	5	29254152
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	LUZP1 CEP170 PRRC2C SVIL MICAL3 GOLGA3 PML TCOF1 LMO7 SRRM2	4.53e-05	360	198	10	33111431
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	RPS6 RUSC2 PRR12 SVIL MKI67 ZC3H18 LMO7 SRRM2 DDX28 RPL8	4.63e-05	361	198	10	30344098
Pubmed	Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation.	NAB2 MKI67 PRX	6.32e-05	14	198	3	19244508
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RPS6 LUZP1 CEP170 SVIL MKI67 TCOF1 BCAR1 C4orf54 TGM2 LMO7 SIPA1L1 SRRM2 RPL8	6.84e-05	626	198	13	33644029
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ABL1 ATR PSMD3 LUZP1 CEP170 PHKA1 STK11 BUB1 RASSF3 BCAR1 CDCA8 PRX ANKRD36B ARHGEF40 LATS2 CHEK2	7.24e-05	910	198	16	36736316
Pubmed	Human transcription factor protein interaction networks.	PSMD3 CHD3 RAD54L2 GMEB2 DMAP1 PRR12 PRRC2C SVIL MKI67 PML ZC3H18 MAP7 POM121C RFXAP PBRM1 PABPN1 LRP2 RACGAP1 DOT1L SRRM2 CPEB1	7.24e-05	1429	198	21	35140242
Pubmed	Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation.	RPS6 CHD3 TCOF1 SRRM2	9.63e-05	42	198	4	26362536
Pubmed	Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.	DMAP1 ZC3H18 PBRM1 SRRM2	9.63e-05	42	198	4	35705031
Pubmed	Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers.	CNTN1 ANK2 PRX	9.64e-05	16	198	3	21745462
Pubmed	Deficiency of the bZIP transcription factors Mafg and Mafk causes misexpression of genes in distinct pathways and results in lens embryonic developmental defects.	HMOX1 MKI67 SIPA1L1	9.64e-05	16	198	3	36092713
Pubmed	Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.	MKI67 RACGAP1	9.64e-05	3	198	2	27284123
Pubmed	Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.	PALB2 CHEK2	9.64e-05	3	198	2	32996020
Pubmed	Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1.	ATR CHEK2	9.64e-05	3	198	2	11715017
Pubmed	The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.	PML CHEK2	9.64e-05	3	198	2	12810724
Pubmed	Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.	MKI67 RACGAP1	9.64e-05	3	198	2	27259241
Pubmed	c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.	ABL1 BMP2	9.64e-05	3	198	2	23821550
Pubmed	Spironolactone rescues Dot1a-Af9-mediated repression of endothelin-1 and improves kidney injury in streptozotocin-induced diabetic rats.	EDN1 DOT1L	9.64e-05	3	198	2	23077601
Pubmed	Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer.	ABL1 WRNIP1	9.64e-05	3	198	2	17888034
Pubmed	Cell Migration and Invadopodia Formation Require a Membrane-binding Domain of CARMIL2.	CARMIL3 CARMIL2	9.64e-05	3	198	2	26578515
Pubmed	Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.	MKI67 ALK	9.64e-05	3	198	2	24811913
Pubmed	Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.	MKI67 RACGAP1	9.64e-05	3	198	2	23135572
Pubmed	The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase.	PKMYT1 STEAP3	9.64e-05	3	198	2	12606722
Pubmed	Atypical E2f functions are critical for pancreas polyploidization.	E2F7 E2F8	9.64e-05	3	198	2	29329320
Pubmed	Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM.	PALB2 CHEK2	9.64e-05	3	198	2	37515473
Pubmed	Coupling of Homologous Recombination and the Checkpoint by ATR.	ATR PALB2	9.64e-05	3	198	2	28089683
Pubmed	PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.	PALB2 CHEK2	9.64e-05	3	198	2	27595995
Pubmed	SHP-1 overexpression increases the radioresistance of NPC cells by enhancing DSB repair, increasing S phase arrest and decreasing cell apoptosis.	ATR CHEK2	9.64e-05	3	198	2	25962492
Pubmed	Different Stages of Quiescence, Senescence, and Cell Stress Identified by Molecular Algorithm Based on the Expression of Ki67, RPS6, and Beta-Galactosidase Activity.	RPS6 MKI67	9.64e-05	3	198	2	33803589
Pubmed	PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2.	PML CHEK2	9.64e-05	3	198	2	12402044
Pubmed	Dynamic Lkb1-TORC1 signaling as a possible mechanism for regulating the endoderm-intestine transition.	RPS6 STK11	9.64e-05	3	198	2	20925120
Pubmed	Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.	E2F7 E2F8	9.64e-05	3	198	2	31475738
Pubmed	Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.	ABL1 PML	9.64e-05	3	198	2	14534537
Pubmed	REGgamma/PA28gamma proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number.	PML CHEK2	9.64e-05	3	198	2	19556897
Pubmed	ATR dependent activation of Chk2.	ATR CHEK2	9.64e-05	3	198	2	16741947
Pubmed	Inhibition of polyploidization in Pten-deficient livers reduces steatosis.	E2F7 E2F8	9.64e-05	3	198	2	35924448
Pubmed	The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.	ATR CHEK2	9.64e-05	3	198	2	17409144
Pubmed	ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage.	ATR CHEK2	9.64e-05	3	198	2	15933716
Pubmed	PIKfyve-dependent regulation of the Cl- channel ClC-2.	CLCN2 PIKFYVE	9.64e-05	3	198	2	19232516
Interaction	TOP3B interactions	MON2 TRPM4 ABL1 PPRC1 ADGRB2 FAM110A SFI1 BIRC6 ABCA7 RNF43 MAPK8IP3 PRR12 TULP4 SVIL NAV2 MICAL3 RC3H2 TRIM41 UBE3B AKNA CHSY1 POM121C ATP13A2 TRAK1 PKMYT1 PIKFYVE RADIL ARHGEF40 LATS2 PABPN1 BTBD7 MARK4 HELZ2 RACGAP1 STEAP3 DOT1L MAPKBP1 ZNF839 DDX28	3.54e-09	1470	191	39	int:TOP3B
Interaction	MAPRE3 interactions	MAP1A LUZP1 CEP170 HROB NAV2 PSRC1 TTF2 KIF21A MAP7 LMO7 SKA3	1.29e-05	230	191	11	int:MAPRE3
Interaction	YWHAG interactions	ABL1 ARHGEF17 LUZP1 AFAP1L1 RUSC2 CEP170 STK11 CASKIN2 PRRC2C SVIL NAV2 WWC1 RC3H2 CARMIL2 BCAR1 MAP7 E2F8 TRAK1 TGM2 RADIL SHROOM1 LATS2 LMO7 SIPA1L1 MARK4 RACGAP1 SKA3 SRRM2	1.89e-05	1248	191	28	int:YWHAG
Interaction	KCTD13 interactions	SART3 DDAH1 MAP1A RPS6 WRNIP1 PSMD3 CHD3 ARHGEF17 JMY LUZP1 MAPK8IP3 CEP170 NDST3 SLC24A2 PRRC2C SVIL MICAL3 PLPPR2 GOLGA3 CNTN1 IQSEC3 SGIP1 CARMIL2 ANK2 MAP7 LMO7 MICAL2 SIPA1L1 SLC4A10 RPL8	2.03e-05	1394	191	30	int:KCTD13
Interaction	SFN interactions	ABL1 MAP1A RPS6 ARHGEF17 LUZP1 RUSC2 CEP170 PRRC2C SVIL NAV2 ZC3H18 BCAR1 TRAK1 LMO7 SIPA1L1 RACGAP1 SKA3 SRRM2 RPL8	3.37e-05	692	191	19	int:SFN
Interaction	YWHAB interactions	ABL1 ARHGEF17 RNF43 LUZP1 AFAP1L1 RUSC2 CEP170 SVIL NAV2 WWC1 RC3H2 CARMIL2 BCAR1 MAP7 E2F8 TRAK1 RADIL SHROOM1 LMO7 SIPA1L1 MARK4 RACGAP1 DOT1L SRRM2	3.41e-05	1014	191	24	int:YWHAB
Interaction	DDX50 interactions	RPS6 CHD3 RNF43 MKI67 PML RC3H2 ZC3H18 DOT1L SRRM2 RPL8 CPEB1	3.58e-05	257	191	11	int:DDX50
Interaction	YWHAH interactions	ABL1 ARHGEF17 LUZP1 RUSC2 CEP170 CASKIN2 PRRC2C SVIL NAV2 WWC1 CARMIL2 BCAR1 MAP7 E2F8 TRAK1 RADIL SHROOM1 LATS2 LMO7 SIPA1L1 MARK4 RACGAP1 SKA3 SRRM2 CPEB1	4.62e-05	1102	191	25	int:YWHAH
Interaction	YWHAE interactions	ABL1 PSMD3 FAM110A RNF43 LUZP1 AFAP1L1 RUSC2 CEP170 SVIL NAV2 GOLGA3 WWC1 RC3H2 CARMIL2 ZC3H18 BCAR1 MAP7 E2F8 TRAK1 RADIL LMO7 SIPA1L1 MARK4 RACGAP1 DOT1L ZNF839 SRRM2	5.65e-05	1256	191	27	int:YWHAE
Interaction	RPGRIP1L interactions	INSYN1 RPS6 SELENOH PSMD3 LUZP1 CEP170 HSDL2 TRIM41 SIPA1L1 RACGAP1	5.95e-05	225	191	10	int:RPGRIP1L
Cytoband	19p13.3	AZU1 PLPPR3 ABCA7 STK11 ONECUT3 MIR7-3HG JSRP1 DOT1L	9.80e-06	237	198	8	19p13.3
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ZFYVE16 SFI1 SH3RF2 MKI67 WWC1 PKMYT1 PHACTR3	1.58e-04	181	115	7	694
GeneFamily	Phospholipid phosphatase related	PLPPR3 PLPPR2	3.96e-04	5	115	2	1127
GeneFamily	E2F transcription factors	E2F7 E2F8	1.10e-03	8	115	2	982
GeneFamily	Adrenoceptors	ADRA1D ADRA2A	1.40e-03	9	115	2	169
GeneFamily	Ring finger proteins	MARCHF10 RNF43 SH3RF2 PML RC3H2 TRIM41 TRIM10	1.89e-03	275	115	7	58
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	SART3 DDAH1 E2F7 FAM110A HROB BUB1 MKI67 PSRC1 TTF2 RC3H2 PTGES2 TCOF1 CHSY1 CDCA8 PALB2 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	1.54e-08	578	196	20	M2368
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP	SART3 DDAH1 E2F7 FAM110A HROB BUB1 MKI67 PSRC1 TTF2 RC3H2 PTGES2 TCOF1 CHSY1 CDCA8 PALB2 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	2.62e-08	597	196	20	MM1309
Coexpression	HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 SKA3	7.74e-07	68	196	7	M41108
Coexpression	GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS	HROB BUB1 MKI67 CDCA8 E2F8 PKMYT1 SKA3 STAG3	1.47e-06	107	196	8	M39165
Coexpression	GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP	SELENOH ABCA7 CASKIN2 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.85e-06	200	196	10	M9437
Coexpression	GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP	E2F7 HROB BUB1 MKI67 RASSF3 PSRC1 MUC20 E2F8 RACGAP1 SKA3	2.85e-06	200	196	10	M3580
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	DDAH1 ADGRB2 HROB LMF2 BUB1 MKI67 MICAL3 PSRC1 PML TCOF1 CDCA8 E2F8 PKMYT1 LMO7 CHEK2 SKA3	9.84e-06	588	196	16	M38992
Coexpression	FAN_EMBRYONIC_CTX_NSC_2	FAM110A BUB1 MKI67 PSRC1 TTF2 CDCA8 LMO7 CHEK2 RACGAP1 SKA3	1.10e-05	233	196	10	M39036
Coexpression	FISCHER_G2_M_CELL_CYCLE	FAM110A BMP2 BUB1 MKI67 PSRC1 SERTAD3 TTF2 CDCA8 CHEK2 RACGAP1	1.23e-05	236	196	10	M130
Coexpression	PRC2_EED_DN.V1_DN	TRPM4 HMOX1 RAD54L2 ARHGEF17 CASKIN2 CDCA8 ATP13A2 BTBD7 MVD	1.58e-05	193	196	9	M2734
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	TTLL3 MAP1A STK11 LMF2 MICAL3 PTGES2 PKMYT1 EFNB2 MVD	2.09e-05	200	196	9	M8039
Coexpression	GSE11924_TFH_VS_TH2_CD4_TCELL_UP	TTLL3 RC3H2 RPH3AL TRIM41 ZC3H18 PBRM1 SLC4A10 MAPKBP1 SRRM2	2.09e-05	200	196	9	M3153
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP	MKI67 TTF2 CDCA8 E2F8 LPO RACGAP1 STAG3 MYBL1	3.27e-05	163	196	8	M8235
Coexpression	KRIEG_HYPOXIA_VIA_KDM3A	SELENOH HMOX1 EDN1 TGM2 STEAP3	4.76e-05	53	196	5	M2467
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	AMZ1 NAB2 PLEKHH1 SVIL NAV2 KIF21A TGM2 MICAL2 MYBL1	5.83e-05	228	196	9	M2151
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_UP	TRPM4 ADRA2A BUB1 CDCA8 PCDH20 RACGAP1 GPRC5B	7.96e-05	137	196	7	M2397
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3	9.64e-05	190	196	8	M761
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL	E2F7 RAD54L2 HROB BUB1 MKI67 PSRC1 TTF2 ANK2 CDCA8 PKMYT1 CHEK2 LRP2 RACGAP1 SKA3	1.01e-04	567	196	14	M45692
Coexpression	HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS	DDAH1 ABL1 ATR SELENOH TTF2 CDCA8 E2F8 PKMYT1 ARHGEF40 CHEK2 LRP2 RACGAP1	1.08e-04	432	196	12	MM419
Coexpression	GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP	INSYN1 RPS6 BIRC6 LMF2 PRRC2C TOGARAM2 MICAL2 STEAP3	1.24e-04	197	196	8	M6191
Coexpression	KOBAYASHI_EGFR_SIGNALING_24HR_DN	BUB1 MKI67 PSRC1 TCOF1 CDCA8 E2F8 PKMYT1 RACGAP1 MYBL1	1.29e-04	253	196	9	M16010
Coexpression	FISCHER_DREAM_TARGETS	E2F7 FAM110A BIRC6 HROB BUB1 MKI67 PSRC1 SERTAD3 TTF2 TCOF1 CDCA8 PALB2 E2F8 PKMYT1 PBRM1 CHEK2 RACGAP1 SKA3 MYBL1	1.30e-04	969	196	19	M149
Coexpression	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	E2F7 HROB BUB1 MUC20 CDCA8 RACGAP1 SKA3 MYBL1	1.37e-04	200	196	8	M3577
Coexpression	GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN	PDCD2 BUB1 MKI67 RC3H2 HSDL2 TRIM41 TRAK1 RACGAP1	1.37e-04	200	196	8	M3607
Coexpression	GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP	NAB2 CEP170 PRR12 SLC24A2 ROPN1L SHROOM1 LATS2 DDX28	1.37e-04	200	196	8	M7917
Coexpression	SERVITJA_LIVER_HNF1A_TARGETS_UP	TRPM4 ADRA2A BUB1 CDCA8 PCDH20 RACGAP1 GPRC5B	1.40e-04	150	196	7	MM936
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST	ABCA7 BUB1 MKI67 TTF2 CDCA8 E2F8 TRIM10 PKMYT1 CHEK2 RACGAP1 STEAP3 SKA3	1.57e-04	450	196	12	M45747
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN	TTLL3 ATP8A2 AZU1 RUSC2 PRRC2C BEND7 MKI67 PML SPATA31C2 CDCA8 ABCC6 LATS2 CCDC149 MICAL2 HELZ2 SRRM2	1.65e-04	746	196	16	M40863
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	AMZ1 E2F7 BUB1 MKI67 TTF2 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	1.70e-04	323	196	10	M2156
Coexpression	ZHONG_PFC_C3_ASTROCYTE	CARMIL3 STK11 GOLGA3 CNTN1 TRIM41 PTPRU SLC4A3 EDEM3 LMO7 DOT1L STAG3	1.79e-04	389	196	11	M39102
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	E2F7 BUB1 MKI67 NAV2 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	5.47e-11	189	197	12	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	E2F7 FAM110A BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3 MYBL1	6.58e-11	192	197	12	0a54c79dcfdeb99e3b512d42b22359618cfd17e9
ToppCell	Transverse-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	AMZ1 BMP2 BUB1 MKI67 PSRC1 VGF CDCA8 E2F8 PKMYT1 TGM2 RACGAP1 SKA3	9.96e-11	199	197	12	7cfe9b2538ea008d67343f3e8bfec3bf81200de6
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	E2F7 BUB1 MKI67 NAV2 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	9.96e-11	199	197	12	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	E2F7 BUB1 MKI67 NAV2 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	9.96e-11	199	197	12	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	E2F7 BUB1 MKI67 NAV2 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	1.06e-10	200	197	12	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F7 GMEB2 PLEKHH1 MKI67 CDCA8 PALB2 E2F8 TRIM10 SHROOM1 MARK4 SKA3	2.38e-10	167	197	11	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	E2F7 HROB BUB1 MKI67 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	2.71e-10	169	197	11	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	E2F7 LMF2 BUB1 MKI67 NAV2 TTF2 CDCA8 PKMYT1 RACGAP1 SKA3 MYBL1	3.70e-10	174	197	11	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	E2F7 LMF2 BUB1 MKI67 NAV2 TTF2 CDCA8 PKMYT1 RACGAP1 SKA3 MYBL1	3.70e-10	174	197	11	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	E2F7 BUB1 MKI67 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	5.31e-10	180	197	11	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	7.95e-10	187	197	11	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	AZU1 E2F7 HROB BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	9.95e-10	191	197	11	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	E2F7 FAM110A BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.05e-09	192	197	11	27723f4e320e49d4a3daafa2d8d3946ff79fab64
ToppCell	Control-Lymphoid-Proliferating_CD4_T_cells\|Control / Condition, Lineage and Cell class	E2F7 HROB BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.11e-09	193	197	11	33d409d6ed1c606337248587ad997ac5f67f081d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 PSRC1 HSDL2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	1.31e-09	196	197	11	5905f0e3061a6b98b7a33d64c782c3dda2cd51ef
ToppCell	Healthy_Control-Lymphoid-T-Proliferating_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	E2F7 HROB BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.38e-09	197	197	11	3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	E2F7 HROB BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	1.62e-09	200	197	11	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	E2F7 BUB1 MKI67 TTF2 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	3.17e-09	163	197	10	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 SPAG8 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RADIL SKA3 MYBL1	5.96e-09	174	197	10	c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 MYBL1	7.82e-09	179	197	10	54191c00b29f53b520cd3243b5791daa4a2c72d7
ToppCell	P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	8.69e-09	181	197	10	e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d
ToppCell	P28-Endothelial-proliferative_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	8.69e-09	181	197	10	2be3d44619adb25d339e7a27b500a56e07e8de01
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 MKI67 RASSF3 PSRC1 TTF2 CDCA8 ABCC6 E2F8 RACGAP1 SKA3	9.16e-09	182	197	10	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	E2F7 BUB1 MKI67 MICAL3 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	1.07e-08	185	197	10	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 HROB BUB1 MKI67 PSRC1 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.07e-08	185	197	10	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3 MYBL1	1.13e-08	186	197	10	9feef5936985e936b3d88f9d1bb012abb6468570
ToppCell	facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3 MYBL1	1.13e-08	186	197	10	89f5b06bc56674af304912d481ac697c7c870904
ToppCell	Dividing_Macrophages-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	HROB BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	1.45e-08	191	197	10	3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.45e-08	191	197	10	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3 MYBL1	1.53e-08	192	197	10	96f23d6e8604d1cb24910d3118d8171b57c93e14
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	E2F7 FAM110A BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3	1.53e-08	192	197	10	026f3e38970bea1e6e8d76a4e2becdfb8484b2ff
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	1.68e-08	194	197	10	f9070035553bc68106a9e0bdf4b507715a138aba
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	1.77e-08	195	197	10	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.86e-08	196	197	10	20383d576708b7e4bfce3e9fe40548cce496e3cb
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.86e-08	196	197	10	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	E2F7 BUB1 MKI67 NAV2 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.95e-08	197	197	10	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MARCHF10 AZU1 ADGRB2 E2F7 PLPPR3 SPAG8 BUB1 ROPN1L RP1 SKA3	2.05e-08	198	197	10	f31790442ef142f1c0c49bf3daf2d0efb193d2c9
ToppCell	Transverse-T_cell-cycling_gd_T\|Transverse / Region, Cell class and subclass	AMZ1 BUB1 MKI67 PSRC1 VGF CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.05e-08	198	197	10	5131b0b7d6c4dd8872cef9f2e233f59f751b4690
ToppCell	Transverse-(1)_T_cell-(18)_cycling_gd_T\|Transverse / shred on region, Cell_type, and subtype	AMZ1 BUB1 MKI67 PSRC1 VGF CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.05e-08	198	197	10	396dddf7ebad41c3a91329b6a280623c0dfdcd2f
ToppCell	(2)_B_cell-(24)_B_cell_cycling\|(2)_B_cell / shred on Cell_type and subtype	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	2.15e-08	199	197	10	d5a9a8a71c4de8cbcef947943f60838731bc640b
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	2.15e-08	199	197	10	a99516a5760f49a69b0fe45a9b2316e393252966
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	E2F7 HROB BUB1 MKI67 TTF2 CDCA8 PKMYT1 RACGAP1 SKA3 MYBL1	2.15e-08	199	197	10	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	Dividing_Macrophages\|World / lung cells shred on cell class, cell subclass, sample id	AZU1 E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.15e-08	199	197	10	5c755b6876e164dc847ef7c723f850f227cf3a87
ToppCell	(1)_T_cells-(1)_T_cell_dividing\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	E2F7 HROB BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.15e-08	199	197	10	33afdd1b1b951b360ababf440bc556fd9e1c1db2
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	E2F7 BUB1 MKI67 PSRC1 TTF2 CDCA8 E2F8 PKMYT1 SKA3 MYBL1	2.25e-08	200	197	10	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative\|Int-URO / Disease, condition lineage and cell class	AMZ1 E2F7 BUB1 MKI67 KIF21A CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.25e-08	200	197	10	99acc1ea01288efdd5b166aa20d66735f2bbe543
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells-Neuroepithelial_cell\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 DNAAF4 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	2.25e-08	200	197	10	c9c832f489629b8724501ddfede984b41a7b674d
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3 MYBL1	2.25e-08	200	197	10	cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 DNAAF4 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	2.25e-08	200	197	10	d7832ab1ed0ff0a6f7e3ac11b2095dc72c90af44
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	2.25e-08	200	197	10	203b9a5de4430713da01b3331e69381db449a3a0
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 CHEK2 RACGAP1 SKA3	2.25e-08	200	197	10	a854e19703dc920e48304541e2b06ed013292f3e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 HROB BUB1 MKI67 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	5.47e-08	165	197	9	eec2d327c94832d1390314c93ef6a2be4648478b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	5.76e-08	166	197	9	2642544070564debe2deb2938d2c33997bf5ef02
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	6.72e-08	169	197	9	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	NS-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC60 DDAH1 MAP1A AZU1 ADGRB2 E2F7 PLPPR3 MXRA5 DNAAF4	7.07e-08	170	197	9	f6a0162bb690dbc19ff1cec64cb933744ad3b496
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 PSRC1 E2F8 PKMYT1 RACGAP1 SKA3 MYBL1	7.07e-08	170	197	9	21bfe070e63722672176052b386167ea4c3dc4e5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 MKI67 PTPRU E2F8 TBC1D8 RACGAP1 SKA3 STAG3 MYBL1	7.44e-08	171	197	9	913bae728b5e653771a27c79a309eb023699f1d0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB2 FNDC1 BUB1 MKI67 TOGARAM2 CDCA8 E2F8 MICAL2 SKA3	7.44e-08	171	197	9	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADGRB2 FNDC1 BUB1 MKI67 TOGARAM2 CDCA8 E2F8 MICAL2 SKA3	7.44e-08	171	197	9	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 MKI67 PTPRU E2F8 TBC1D8 RACGAP1 SKA3 STAG3 MYBL1	7.44e-08	171	197	9	f28b2336057e353b96a6ff4581ec9fd0ca0789d9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 NAV2 PSRC1 E2F8 PKMYT1 SKA3 MYBL1	7.44e-08	171	197	9	c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	8.22e-08	173	197	9	a25459b8140b0dbcb73e3b4cc1407b679229f25c
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	E2F7 BUB1 MKI67 PSRC1 CDCA8 PKMYT1 SLITRK5 RACGAP1 MYBL1	9.52e-08	176	197	9	45c6983ab671b0f306e7390320bd84f848e474cc
ToppCell	368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	BUB1 MKI67 SGIP1 CDCA8 SH3D21 EDN1 E2F8 PKMYT1 SKA3	9.99e-08	177	197	9	844017225e9039d1bc621a9630a30c2e9a51b36d
ToppCell	Dividing_Macrophages-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	AZU1 E2F7 FAM110A HROB MKI67 CDCA8 PKMYT1 RACGAP1 SKA3	1.05e-07	178	197	9	6557688c6790a5bcc3b9aea5b8789cf9506b3c54
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 PKMYT1 CHEK2 RACGAP1 DOT1L SKA3 MYBL1	1.10e-07	179	197	9	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Ccnb1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RNF43 BUB1 MKI67 TTF2 CDCA8 E2F8 CHEK2 INAVA	1.14e-07	129	197	8	ff74d159034a09f7b174da18bfb9a26936252b4c
ToppCell	LPS-antiTNF-Unknown\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADRA1D BUB1 MKI67 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.14e-07	129	197	8	739b263296c28554967362060b154f7a95e1341d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 BUB1 MKI67 TTF2 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.15e-07	180	197	9	401df9cddcbca1eb8f0d2687bcacd98e95dc1493
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMOX1 RNF43 NAV2 WWC1 HSDL2 KIF21A MAP7 LMO7 MICAL2	1.15e-07	180	197	9	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INSYN1 MAP1A ATP8A2 NDST3 BMP2 FOXS1 SGIP1 ARHGEF40 MARK4	1.15e-07	180	197	9	79c5725f02e038d0187f4a1e1591f2492538aa57
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 HROB BUB1 MKI67 CDCA8 E2F8 PKMYT1 SKA3 MYBL1	1.15e-07	180	197	9	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4\|E18.5-samps / Age Group, Lineage, Cell class and subclass	GGN BUB1 MKI67 TCOF1 CDCA8 TRIM10 SKA3 TNXB	1.21e-07	130	197	8	169d88bffd7cd813a484d809defa638ceaca4bcb
ToppCell	LPS-antiTNF-Unknown-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADRA1D BUB1 MKI67 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.21e-07	130	197	8	615c233c7c2600c1c2bc5cf5b1c501fc474564ef
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BUB1 MKI67 RASSF3 TTF2 CDCA8 ABCC6 E2F8 RACGAP1 SKA3	1.27e-07	182	197	9	0fc45214f0b0766f69be6eff69cc4bec574023aa
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADRA1D BUB1 MKI67 SGIP1 CDCA8 E2F8 RACGAP1 SKA3	1.36e-07	132	197	8	02491930097b75aaeedab9e8200711b0dc610944
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	E2F7 SH3RF2 BUB1 MKI67 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.39e-07	184	197	9	6b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell	343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	E2F7 SH3RF2 BUB1 MKI67 CDCA8 E2F8 RACGAP1 SKA3 MYBL1	1.39e-07	184	197	9	e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	E2F7 HROB BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.46e-07	185	197	9	a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC60 E2F7 ADRA1D BUB1 MKI67 E2F8 PKMYT1 SKA3	1.52e-07	134	197	8	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	Dividing_Macrophages-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.52e-07	186	197	9	0067eb78d4c7e32b9563550d9fcaf13445ee6a48
ToppCell	MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)\|MatrixFB / shred on cell class and cell subclass (v4)	SELENOH E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 RACGAP1 SKA3	1.67e-07	188	197	9	b240ea20750ffb825cb5fe41d06c632233406ab6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 AFAP1L1 HROB BUB1 MKI67 CDCA8 E2F8 PKMYT1 SKA3	1.83e-07	190	197	9	31de1727822e9818652946dfb962daee77ffad68
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	AMZ1 MAPK8IP3 CEP170 MICAL3 TCOF1 KHDRBS2 TRAK1 PIKFYVE SIPA1L1	1.83e-07	190	197	9	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	Int-URO-Lymphocyte-T_NK-T_NK_proliferative\|Int-URO / Disease, Lineage and Cell Type	E2F7 BUB1 MKI67 KIF21A CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	1.83e-07	190	197	9	005967c540418b85311308072a07c684f4296aef
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAM110A BUB1 MKI67 PSRC1 CDCA8 E2F8 CHEK2 RACGAP1 SKA3	1.91e-07	191	197	9	0ba5b112a82e489f5a21966f78a403a7436ce73b
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.00e-07	192	197	9	5ef79faddb433c09ff36660d8bf7a3af5a67bf1d
ToppCell	P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.09e-07	193	197	9	0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd
ToppCell	P07-Endothelial-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.09e-07	193	197	9	1e95ef29357969ee385b4717c0b5a497390ac260
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|normal_Lymph_Node / Location, Cell class and cell subclass	BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3 STAG3	2.09e-07	193	197	9	5ce93860bc60ce6ecfed3a3d985f84e28781eec1
ToppCell	P03-Endothelial-proliferative_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.18e-07	194	197	9	22bcfb0f3f73608feb22c0847ab4d34f87aeede0
ToppCell	P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SELENOH E2F7 BUB1 MKI67 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.18e-07	194	197	9	5e56ce9b9fe0721be3a9e6efe1422599bb867721
ToppCell	Dividing_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	E2F7 BUB1 MKI67 PSRC1 CDCA8 E2F8 PKMYT1 RACGAP1 SKA3	2.28e-07	195	197	9	79ee423df85aa1631b7bdea74eacaf826dfc4a2c
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELENOH BUB1 MKI67 PSRC1 CDCA8 CHEK2 RACGAP1 SKA3 MYBL1	2.28e-07	195	197	9	5790b47b0e028e49b99bda8d6d9e80ac79208cdf
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	MON2 HMOX1 ARHGEF17 RNF43 HROB NAV2 PLPPR2 PML TRAK1 BTBD7 MAPKBP1	7.87e-07	191	194	11	5344_UP
Drug	2,4,4'-trichlorobiphenyl	CCDC60 ATR MYT1 NAB2 E2F7 PLPPR3 RNF43 FNDC1 BEND7 BUB1 MKI67 NAV2 INSM2 RASSF3 PSRC1 TTF2 IQSEC3 PTPRU MAP7 CDCA8 PALB2 E2F8 PRX PBRM1 MICAL2 HELZ2 SLC4A10 FAM217B RACGAP1 SKA3 GPRC5B	1.13e-06	1411	194	31	ctd:C081766
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A	TRPM4 ATP8A2 MAPK8IP3 STK11 HROB CASKIN2 CNTN1 PML TCOF1 RFXAP BTBD7	1.18e-06	199	194	11	5085_UP
Drug	2,4,5,2',5'-pentachlorobiphenyl	CCDC60 ATR MYT1 NAB2 E2F7 PLPPR3 RNF43 FNDC1 BEND7 BUB1 MKI67 NAV2 INSM2 RASSF3 PSRC1 TTF2 IQSEC3 PTPRU MAP7 CDCA8 PALB2 E2F8 PRX PBRM1 MICAL2 HELZ2 SLC4A10 FAM217B RACGAP1 SKA3 GPRC5B	1.75e-06	1441	194	31	ctd:C009828
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	TULP4 BUB1 MKI67 PSRC1 WWC1 TCOF1 CDCA8 E2F8 PABPN1 RACGAP1	2.85e-06	176	194	10	958_DN
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	HMOX1 ABCA7 MAPK8IP3 LMF2 NAV2 PML PTPRU TRAK1 TGM2 STAG3	4.45e-06	185	194	10	6243_UP
Drug	Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	TRPM4 SFI1 ABCA7 ADRA1D ALK PML UBE3B SH3D21 SIPA1L1 MVD	7.09e-06	195	194	10	7406_UP
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	TRPM4 MAP1A MYT1 SFI1 RAD54L2 SPAG8 ABCA7 MICAL3 PML KHDRBS2	7.09e-06	195	194	10	4124_UP
Drug	clozapine; Up 200; 10uM; MCF7; HT_HG-U133A	SFI1 HMOX1 ABCA7 RUSC2 LMF2 CASKIN2 ANK2 SH3D21 TRAK1 SIPA1L1	7.42e-06	196	194	10	5226_UP
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; PC3; HT_HG-U133A	CHD3 HMOX1 RNF43 NAV2 SERTAD3 PML EFNB2 MARK4 SLITRK5 ZNF839	7.76e-06	197	194	10	7267_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HMOX1 STK11 LMF2 CLCN2 CASKIN2 MICAL3 PLPPR2 PML TGM2 GPRC5B	8.11e-06	198	194	10	5242_DN
Drug	Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; HL60; HT_HG-U133A	CHD3 SFI1 RAD54L2 ABCA7 PLPPR2 CNTN1 ANK2 TCOF1 MARK4 ZNF839	8.47e-06	199	194	10	3140_DN
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	CHD3 RNF43 LUZP1 CASKIN2 NAV2 CNTN1 PTPRU BTBD7 MARK4 STAG3	8.47e-06	199	194	10	5337_UP
Drug	Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A	TRPM4 MAP1A SFI1 RUSC2 HROB LMF2 PML MARK4 LRP2 SRRM2	8.47e-06	199	194	10	3264_UP
Drug	Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A	ADGRB2 ABCA7 RNF43 MAPK8IP3 HROB CLCN2 PLPPR2 UBE3B TRAK1 TGM2	8.47e-06	199	194	10	7496_UP
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; HL60; HT_HG-U133A	NAB2 LMF2 PML PTGES2 UBE3B ATP13A2 SIPA1L1 SLITRK5 ZNF839 MVD	8.47e-06	199	194	10	1270_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A	SPAG8 BUB1 MKI67 PLPPR2 PSRC1 PML CDCA8 CHEK2 SLITRK5	2.86e-05	183	194	9	7389_DN
Drug	2,4,5-Trichlorophenoxyacetic Acid	ADGRB2 HMOX1 ABCA7 SLC24A2 SVIL TBC1D8 MVD	3.72e-05	107	194	7	ctd:D015085
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	ZFYVE16 CHD3 TULP4 MKI67 MICAL3 VGF PTPRU PIKFYVE MICAL2	3.99e-05	191	194	9	4168_DN
Drug	Hexetidine [141-94-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SFI1 RUSC2 STK11 SVIL PLPPR2 VGF TRAK1 TGM2 MARK4	4.16e-05	192	194	9	3318_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Up 200; 12uM; PC3; HT_HG-U133A	MAP1A ATP8A2 HMOX1 BMP2 PML VGF MAP7 SIPA1L1 CHEK2	4.16e-05	192	194	9	5812_UP
Drug	Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	TRPM4 CHD3 GMEB2 STK11 VGF TCOF1 MAPKBP1 STAG3 DDX28	4.69e-05	195	194	9	1700_DN
Drug	(-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	MAP1A SFI1 MAPK8IP3 ADRA1D VGF ANK2 KHDRBS2 TRAK1 GPRC5B	4.69e-05	195	194	9	874_UP
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	NAB2 RAD54L2 SPAG8 ARHGEF17 RUSC2 BUB1 VGF ARHGEF40 ZNF839	4.69e-05	195	194	9	4597_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	CHD3 RAD54L2 ARHGEF17 MAPK8IP3 LMF2 TCOF1 TRAK1 MARK4 ZNF839	4.69e-05	195	194	9	4706_DN
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NAB2 SFI1 SPAG8 HROB PML RFXAP TGM2 GPRC5B MYBL1	4.69e-05	195	194	9	6808_UP
Drug	Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A	CHD3 SFI1 SVIL ALK SERTAD3 PML RFXAP MARK4 LRP2	4.88e-05	196	194	9	2393_DN
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	RAD54L2 SPAG8 LUZP1 ADRA1D CLCN2 VGF TRAK1 LRP2 SRRM2	4.88e-05	196	194	9	3233_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	MYT1 RAD54L2 MAPK8IP3 CASKIN2 MICAL3 VGF KHDRBS2 BTBD7 MARK4	4.88e-05	196	194	9	6744_DN
Drug	Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A	ATP8A2 HMOX1 RUSC2 NAV2 RFXAP TGM2 MICAL2 DDX28 MYBL1	4.88e-05	196	194	9	5255_UP
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	RNF43 RUSC2 LMF2 PML TTF2 TCOF1 LMO7 MARK4 ZNF839	5.08e-05	197	194	9	2637_UP
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HMOX1 ABCA7 HROB LMF2 CNTN1 PTPRU TRAK1 EDEM3 TGM2	5.08e-05	197	194	9	3292_UP
Drug	Ciprofibrate [52214-84-3]; Down 200; 13.8uM; HL60; HT_HG-U133A	NAB2 SFI1 BMP2 PML EFNB2 MARK4 SLITRK5 MVD MYBL1	5.08e-05	197	194	9	6138_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	RNF43 LUZP1 STK11 CASKIN2 PLPPR2 VGF TGM2 ZNF839 STAG3	5.08e-05	197	194	9	2773_DN
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	MON2 RAD54L2 SPAG8 HROB CNTN1 SH3D21 TRAK1 TGM2 DDX28	5.08e-05	197	194	9	2751_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A	NAB2 ABCA7 HROB PLPPR2 TRAK1 TGM2 BTBD7 LRP2 GPRC5B	5.08e-05	197	194	9	3622_DN
Drug	Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A	NAB2 ADGRB2 SPAG8 ABCA7 MAPK8IP3 RUSC2 MAP7 TRAK1 LMO7	5.28e-05	198	194	9	7317_UP
Drug	Clopamide [636-54-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	CHD3 SFI1 MICAL3 PML HSDL2 EDEM3 STEAP3 ZNF839 SRRM2	5.28e-05	198	194	9	6301_DN
Drug	wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A	SFI1 RAD54L2 RUSC2 STK11 LMF2 PLPPR2 PML ANK2 MVD	5.28e-05	198	194	9	6202_DN
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A	SPAG8 CASKIN2 PML RFXAP TRAK1 TGM2 BTBD7 SIPA1L1 MVD	5.49e-05	199	194	9	5617_DN
Drug	Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; PC3; HT_HG-U133A	SFI1 LMF2 CASKIN2 ALK PML MAP7 ARHGEF40 LRP2 STAG3	5.49e-05	199	194	9	5879_UP
Drug	Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	MON2 SFI1 SPAG8 SLC24A2 BUB1 CACNA1G PML PRX CPEB1	5.71e-05	200	194	9	5432_UP
Drug	trimazosin	ADRA1D ADRA2A LATS2	6.99e-05	10	194	3	CID000037264
Drug	fullerene C60	SART3 CCDC60 TRPM4 ABL1 PPRC1 RNF43 MAPK8IP3 PLEKHH1 BMP2 STK11 ADRA1D ADRA2A CASKIN2 CACNA1G WNK4 GOLGA3 AKNA BCAR1 ATP13A2 PRX PIKFYVE TGM2 LIPC LATS2 MIXL1 LPO HELZ2 CPEB1	7.40e-05	1498	194	28	ctd:C069837
Drug	NaCl	PPRC1 ATP8A2 RPS6 AZU1 HMOX1 SPAG8 BMP2 CLCN2 NAV2 WNK4 PTGES2 EDN1 PIKFYVE LIPC PHACTR3	1.05e-04	564	194	15	CID000005234
Drug	resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SART3 BUB1 MKI67 PSRC1 CDCA8 E2F8 MARK4 RACGAP1	1.44e-04	177	194	8	841_DN
Drug	Methamphetamine	DDAH1 ABL1 MAP1A ZFYVE16 RPS6 MYT1 NAB2 FAM110A SFI1 HMOX1 SPAG8 MAPK8IP3 NDST3 LMF2 PRRC2C SVIL MKI67 MICAL3 PLPPR2 VGF CDCA8 SLC4A3 ABCC6 LMO7 SRRM2 MVD	1.54e-04	1401	194	26	ctd:D008694
Drug	Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	MYT1 HMOX1 RNF43 LMF2 PML TGM2 MARK4 SRRM2	2.09e-04	187	194	8	5025_UP
Drug	alprenolol	PDCD2 PPRC1 ADRA1D ADRA2A LATS2	2.16e-04	64	194	5	CID000002119
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RAD54L2 BUB1 MKI67 PSRC1 PML CDCA8 MARK4 MVD	2.25e-04	189	194	8	3214_DN
Drug	Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A	NAB2 SPAG8 SLC24A2 CNTN1 VGF EDN1 TGM2 MYBL1	2.41e-04	191	194	8	3377_UP
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	RUSC2 NAV2 CNTN1 UBE3B PRX TGM2 MARK4 LRP2	2.41e-04	191	194	8	5917_UP
Drug	Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A	TRPM4 NAB2 SFI1 NAV2 EDN1 TRAK1 TGM2 MYBL1	2.50e-04	192	194	8	5620_UP
Drug	rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A	MAP1A NAB2 SFI1 BMP2 PTGES2 RFXAP SIPA1L1 LRP2	2.50e-04	192	194	8	1174_UP
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	RAD54L2 CASKIN2 PML VGF KHDRBS2 TGM2 MAPKBP1 SRRM2	2.59e-04	193	194	8	1647_UP
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	TRPM4 NAB2 SFI1 HMOX1 ARHGEF17 RNF43 CASKIN2 SIPA1L1	2.59e-04	193	194	8	5440_DN
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A	BMP2 CASKIN2 BUB1 PLPPR2 PML VGF UBE3B ZNF839	2.59e-04	193	194	8	4067_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	PLPPR3 SFI1 SPAG8 MAPK8IP3 KHDRBS2 MICAL2 BTBD7 SLITRK5	2.59e-04	193	194	8	2675_DN
Drug	Tadjakonine [11087-94-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	MYT1 ARHGEF17 RUSC2 BUB1 PLPPR2 SIPA1L1 MARK4 GPRC5B	2.68e-04	194	194	8	4424_DN
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; PC3; HT_HG-U133A	MON2 ATP8A2 HMOX1 SPAG8 LMF2 SRRM2 DDX28 MVD	2.68e-04	194	194	8	4506_UP
Drug	Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	MAP1A MYT1 RAD54L2 STK11 CASKIN2 BUB1 PML VGF	2.68e-04	194	194	8	4174_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	TRPM4 ADGRB2 RAD54L2 RUSC2 HROB CASKIN2 BUB1 LMO7	2.68e-04	194	194	8	4331_DN
Drug	Halcinonide [3093-35-4]; Up 200; 8.8uM; PC3; HT_HG-U133A	SFI1 SPAG8 BMP2 SLC24A2 NAV2 PML EFNB2 STAG3	2.68e-04	194	194	8	3680_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A	SFI1 SPAG8 ABCA7 SVIL PML EFNB2 SIPA1L1 STEAP3	2.68e-04	194	194	8	2434_DN
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	SFI1 MAPK8IP3 HROB LMF2 SH3D21 TRAK1 ARHGEF40 MARK4	2.68e-04	194	194	8	6507_UP
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	MON2 MAP1A ADGRB2 RAD54L2 PTPRU E2F8 SLITRK5 STAG3	2.68e-04	194	194	8	4325_DN
Drug	bisoprolol	PDCD2 ADRA1D ADRA2A EDN1	2.71e-04	37	194	4	CID000002405
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	NAB2 SFI1 HMOX1 RUSC2 SVIL KHDRBS2 TGM2 MYBL1	2.78e-04	195	194	8	3346_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	NAB2 LMF2 WWC1 PTPRU PKMYT1 SRRM2 GPRC5B MYBL1	2.78e-04	195	194	8	3278_UP
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	NAB2 ADGRB2 HMOX1 BUB1 PLPPR2 ALK CNTN1 BTBD7	2.78e-04	195	194	8	3737_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	ABCA7 RUSC2 STK11 NAV2 CNTN1 PML TGM2 MYBL1	2.78e-04	195	194	8	5405_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A	HMOX1 LUZP1 ADRA1D RFXAP TRAK1 MICAL2 BTBD7 SIPA1L1	2.78e-04	195	194	8	5455_DN
Drug	STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A	PDCD2 ABCA7 RUSC2 PRRC2C PML MAP7 LMO7 SRRM2	2.78e-04	195	194	8	6561_UP
Drug	17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A	PDCD2 ATP13A2 E2F8 MICAL2 CHEK2 STEAP3 STAG3 DDX28	2.78e-04	195	194	8	6973_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	CASKIN2 TCOF1 ATP13A2 SIPA1L1 MAPKBP1 SRRM2 STAG3 MVD	2.78e-04	195	194	8	3408_DN
Drug	Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A	SFI1 RAD54L2 SVIL PLPPR2 KHDRBS2 ATP13A2 DDX28 MYBL1	2.78e-04	195	194	8	6245_UP
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	NAB2 SPAG8 ALK SH3D21 BTBD7 LRP2 MVD MYBL1	2.78e-04	195	194	8	1162_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	TRPM4 HMOX1 RAD54L2 LUZP1 MAPK8IP3 RUSC2 CLCN2 ATP13A2	2.78e-04	195	194	8	4707_DN
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	RAD54L2 MAPK8IP3 STK11 PLPPR2 PML ATP13A2 BTBD7 MARK4	2.78e-04	195	194	8	2852_DN
Drug	Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SFI1 SPAG8 ARHGEF17 HROB CNTN1 SH3D21 TGM2 MARK4	2.78e-04	195	194	8	3321_UP
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MAP1A ATP8A2 SPAG8 HROB SVIL PML SLC4A3 SRRM2	2.78e-04	195	194	8	4424_UP
Drug	Coal Tar	DDAH1 E2F7 SFI1 HMOX1 FNDC1 TULP4 MKI67 TCOF1 EDN1 E2F8 RACGAP1	2.78e-04	360	194	11	ctd:D003033
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A	LUZP1 LMF2 ALK PML MAP7 BTBD7 SLITRK5 SRRM2	2.87e-04	196	194	8	2382_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A	SART3 ABL1 SFI1 HMOX1 LMF2 PML TRAK1 ZNF839	2.87e-04	196	194	8	3633_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A	TRPM4 NAB2 CHD3 ABCA7 MAPK8IP3 PLPPR2 PML TRAK1	2.87e-04	196	194	8	5569_DN
Drug	Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; MCF7; HT_HG-U133A	NAB2 CHD3 LUZP1 TRAK1 EDEM3 BTBD7 SIPA1L1 ZNF839	2.87e-04	196	194	8	4775_DN
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A	ARHGEF17 ABCA7 STK11 HROB BUB1 PLPPR2 SLC4A3 TRAK1	2.87e-04	196	194	8	4570_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	NAB2 SFI1 HMOX1 CASKIN2 SERTAD3 UBE3B MICAL2 STAG3	2.87e-04	196	194	8	6772_DN
Drug	Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A	CHD3 HMOX1 LMF2 SERTAD3 EDEM3 PABPN1 STAG3 GPRC5B	2.87e-04	196	194	8	1678_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MYT1 HMOX1 RAD54L2 ARHGEF17 CACNA1G TTF2 LRP2 MVD	2.87e-04	196	194	8	3314_UP
Drug	Imipramine hydrochloride [113-52-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	TRPM4 CHD3 BMP2 BUB1 MKI67 MARK4 ZNF839 CPEB1	2.87e-04	196	194	8	1807_DN
Drug	Kaempferol [520-18-3]; Up 200; 14uM; MCF7; HT_HG-U133A	STK11 BUB1 NAV2 CNTN1 PML TGM2 SIPA1L1 MYBL1	2.87e-04	196	194	8	3579_UP
Drug	LY294002; Down 200; 10uM; PC3; HT_HG-U133A	MAP1A ATP8A2 NAB2 ADGRB2 ADRA1D PML ARHGEF40 DDX28	2.87e-04	196	194	8	5970_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	CHD3 HMOX1 RAD54L2 LMF2 CASKIN2 NAV2 VGF MYBL1	2.87e-04	196	194	8	1666_UP
Drug	alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A	MAP1A RUSC2 LMF2 PML MAP7 SIPA1L1 LRP2 MVD	2.87e-04	196	194	8	1151_UP
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A	ADGRB2 SPAG8 PML VGF PTGES2 UBE3B SLC4A3 PKMYT1	2.87e-04	196	194	8	4591_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	SFI1 HMOX1 RAD54L2 SPAG8 MAPK8IP3 RUSC2 PML SRRM2	2.87e-04	196	194	8	5232_UP
Drug	Molindone hydrochloride [15622-65-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A	SART3 MAP1A NAB2 ADGRB2 SFI1 KHDRBS2 BTBD7 MARK4	2.87e-04	196	194	8	7337_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	SPAG8 RUSC2 CNTN1 PTPRU TGM2 ARHGEF40 MICAL2 MAPKBP1	2.87e-04	196	194	8	6785_UP
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	TRPM4 MAP1A RAD54L2 SPAG8 LMF2 TRAK1 EDEM3 SRRM2	2.98e-04	197	194	8	7351_UP
Disease	Colorectal Carcinoma	TTLL3 RNF43 NDST3 BMP2 STK11 BUB1 MKI67 PLPPR2 CNTN1 ANK2 TCOF1 PTPRU ABCC6 TGM2 LMO7 CHEK2 LRP2	4.75e-06	702	195	17	C0009402
Disease	Hepatorenal Syndrome	HMOX1 EDN1	4.35e-05	2	195	2	C0019212
Disease	Malignant neoplasm of pancreas	RNF43 STK11 BUB1 BCAR1 PALB2 TGM2	6.13e-05	102	195	6	C0346647
Disease	Disease Exacerbation	RPS6 E2F7 ABCA7 MKI67 ABCC6 E2F8 CHEK2	1.19e-04	165	195	7	C0235874
Disease	PR interval	STK11 ZNF469 CASKIN2 BEND7 NAV2 CACNA1G UBE3B TRAK1 TGM2 ARHGEF40 MICAL2 SIPA1L1	1.22e-04	495	195	12	EFO_0004462
Disease	myeloid white cell count	ABL1 AMZ1 PSMD3 ABCA7 BEND7 RASSF3 RMC1 SERTAD3 CHSY1 PRX TBC1D8 TGM2 LIPC MICAL2 MARK4 RP1 DOT1L	1.75e-04	937	195	17	EFO_0007988
Disease	nephrosis (biomarker_via_orthology)	PTPRU EDN1 LRP2	3.99e-04	22	195	3	DOID:2527 (biomarker_via_orthology)
Disease	stroke	CHD3 RNF43 ANK2 C4orf54 MICAL2 BTBD7	4.04e-04	144	195	6	EFO_0000712
Disease	coronary artery disease (is_implicated_in)	DDAH1 HMOX1 ABCC6 EDN1 LIPC	5.42e-04	100	195	5	DOID:3393 (is_implicated_in)
Disease	Pancreatic Neoplasm	RNF43 STK11 BCAR1 PALB2 TGM2	5.42e-04	100	195	5	C0030297
Disease	antiphospholipid antibody measurement	MICAL3 SGIP1 KHDRBS2	5.87e-04	25	195	3	EFO_0005200
Disease	X-11423--O-sulfo-L-tyrosine measurement	MYT1 PKMYT1	6.40e-04	6	195	2	EFO_0021231
Disease	hepatopulmonary syndrome (biomarker_via_orthology)	HMOX1 EDN1	6.40e-04	6	195	2	DOID:900 (biomarker_via_orthology)
Disease	Porokeratosis, Disseminated Superficial Actinic	SART3 MVD	6.40e-04	6	195	2	C0265970
Disease	myeloblastin measurement	AZU1 PSMD3	6.40e-04	6	195	2	EFO_0020585
Disease	PROSTATE CANCER, HEREDITARY, 1	CHD3 RNF43 RASSF3 CHEK2	6.75e-04	60	195	4	C4722327
Disease	Malignant tumor of breast	STK11 PALB2 CHEK2	7.40e-04	27	195	3	cv:C0006142
Disease	Breast neoplasm	STK11 PALB2 CHEK2	7.40e-04	27	195	3	cv:C1458155
Disease	Familial cancer of breast	STK11 PALB2 CHEK2	7.40e-04	27	195	3	cv:C0346153
Disease	Malignant neoplasm of breast	ABL1 RPS6 HMOX1 BMP2 LMF2 BEND7 MKI67 ALK ANK2 BCAR1 PCDH20 PALB2 TGM2 PBRM1 SIPA1L1 CHEK2 FAM217B	8.23e-04	1074	195	17	C0006142
Disease	electrocardiography	GMEB2 LUZP1 SVIL NAV2 CACNA1G SGIP1 JSRP1 SLC4A3 TRAK1 RADIL SIPA1L1	8.52e-04	530	195	11	EFO_0004327
Disease	cytotoxicity measurement, response to clozapine	MYT1 PLPPR2 PKMYT1	9.15e-04	29	195	3	EFO_0006952, GO_0097338
Disease	Neoplasm of uncertain or unknown behavior of ovary	ATR RNF43 STK11	9.15e-04	29	195	3	C0496920
Disease	Ovarian Carcinoma	ATR RNF43 STK11	1.01e-03	30	195	3	C0029925
Disease	Prostate cancer, familial	CHD3 RNF43 RASSF3 CHEK2	1.14e-03	69	195	4	C2931456
Disease	endometrial cancer (implicated_via_orthology)	ATR STK11	1.19e-03	8	195	2	DOID:1380 (implicated_via_orthology)
Disease	female breast cancer (is_implicated_in)	PALB2 CHEK2	1.19e-03	8	195	2	DOID:0050671 (is_implicated_in)
Disease	tumor necrosis factor receptor superfamily member 19L measurement	ARHGEF17 PIKFYVE	1.19e-03	8	195	2	EFO_0008309
Disease	colorectal cancer (is_implicated_in)	ABL1 RNF43 BUB1 MKI67 CHEK2	1.28e-03	121	195	5	DOID:9256 (is_implicated_in)
Disease	longitudinal alcohol consumption measurement	ADRA2A SPATA31C2	1.52e-03	9	195	2	EFO_0007645
Disease	Hypertensive disease	HMOX1 STK11 ADRA2A WNK4 EDN1 TGM2	1.70e-03	190	195	6	C0020538
Disease	coagulation factor XA measurement	FAM110A AKNA	2.30e-03	11	195	2	EFO_0020266
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	RPH3AL PTPRU	2.30e-03	11	195	2	EFO_0004471, EFO_0009131
Disease	Neoplasm of uncertain or unknown behavior of breast	PALB2 PBRM1 CHEK2	2.52e-03	41	195	3	C0496956
Disease	Breast adenocarcinoma	PALB2 PBRM1 CHEK2	2.52e-03	41	195	3	C0858252
Disease	neutrophil percentage of leukocytes	PSMD3 SFI1 ABCA7 STK11 ADRA2A BEND7 SERTAD3 CHSY1 ZC3H18 TBC1D8 MARK4	2.58e-03	610	195	11	EFO_0007990
Disease	Glioma	ATR CLCN2 ALK MYBL1	2.68e-03	87	195	4	C0017638
Disease	Sclerocystic Ovaries	CARMIL3 MAPK8IP3 JSRP1 RACGAP1 MYBL1	2.75e-03	144	195	5	C1136382
Disease	Polycystic Ovary Syndrome	CARMIL3 MAPK8IP3 JSRP1 RACGAP1 MYBL1	2.75e-03	144	195	5	C0032460
Disease	sexual dimorphism measurement	BRPF3 AMZ1 RAD54L2 HROB RMC1 GDF5-AS1 DNAAF4 SPATA31C2 CHSY1 ATP13A2 ARHGEF40 LIPC SP6 DOT1L MAPKBP1 GPRC5B	2.89e-03	1106	195	16	EFO_0021796
Disease	Breast Carcinoma	ABL1 RPS6 HMOX1 BMP2 MKI67 ALK PALB2 TGM2 PBRM1 CHEK2	3.23e-03	538	195	10	C0678222
Disease	coagulation factor X measurement	FAM110A AKNA	3.23e-03	13	195	2	EFO_0020265
Disease	Benign tumor of pancreas	RNF43 STK11	3.23e-03	13	195	2	C0347284
Disease	hypothyroidism (implicated_via_orthology)	PHKA1 LIPC	3.23e-03	13	195	2	DOID:1459 (implicated_via_orthology)
Disease	heart rate variability measurement, response to antipsychotic drug	NAV2 KHDRBS2 E2F8	3.50e-03	46	195	3	EFO_0008003, GO_0097332
Disease	cortical surface area measurement	MON2 DDAH1 ATP8A2 AMZ1 MYT1 LUZP1 AFAP1L1 BMP2 ZNF469 CLCN2 PRRC2C NAV2 WWC1 ATP13A2 PKMYT1 EFNB2 SLC4A10 TNXB	3.67e-03	1345	195	18	EFO_0010736
Disease	membranous glomerulonephritis (biomarker_via_orthology)	PTPRU LRP2	3.75e-03	14	195	2	DOID:10976 (biomarker_via_orthology)
Disease	urinary bladder cancer (biomarker_via_orthology)	MKI67 CHEK2	3.75e-03	14	195	2	DOID:11054 (biomarker_via_orthology)
Disease	Hereditary Breast and Ovarian Cancer Syndrome	PALB2 CHEK2	3.75e-03	14	195	2	C0677776
Disease	Non-Small Cell Lung Carcinoma	E2F7 STK11 ALK MXRA5 E2F8	3.87e-03	156	195	5	C0007131
Disease	BMI-adjusted adiponectin measurement	ALK PBRM1	4.31e-03	15	195	2	EFO_0007737
Disease	anemia (implicated_via_orthology)	SLC4A3 SLC4A10	4.31e-03	15	195	2	DOID:2355 (implicated_via_orthology)
Disease	lifestyle measurement	RMC1 WWC1 SGIP1 KHDRBS2 EDEM3 SLC4A10	4.86e-03	235	195	6	EFO_0010724
Disease	Schizoaffective disorder-bipolar type	MYT1 PKMYT1	4.91e-03	16	195	2	EFO_0009965
Disease	Pre-Eclampsia	HMOX1 EDN1	4.91e-03	16	195	2	C0032914
Disease	Hypermetropia	TULP4 PTPRU MARK4 STEAP3	4.92e-03	103	195	4	HP_0000540
Disease	neuroimaging measurement	DDAH1 AMZ1 LUZP1 MAPK8IP3 AFAP1L1 BMP2 ZNF469 PRRC2C NAV2 WWC1 GDF5-AS1 FBXL19-AS1 POM121C ATP13A2 SLC4A10	5.12e-03	1069	195	15	EFO_0004346
Disease	Alzheimer disease	ABCA7 BMP2 PRRC2C CACNA1G WWC1 LIPC MARK4 SP6 TNXB	5.17e-03	485	195	9	MONDO_0004975
Disease	immature granulocyte count	PSMD3 MARK4	5.54e-03	17	195	2	EFO_0803542
Disease	amino acid measurement	ZFYVE16 MYT1 E2F7 NDST3 ADRA1D ADRA2A MYCNOS ALK PKMYT1 MARK4 LRP2	5.67e-03	678	195	11	EFO_0005134
Disease	lipoprotein A measurement	PSMD3 FNDC1 TULP4 PSRC1	6.60e-03	112	195	4	EFO_0006925
Disease	pancreatic cancer (is_implicated_in)	ATR STK11 MKI67 PALB2	6.60e-03	112	195	4	DOID:1793 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
ARPEGTPRRAAKTVA	ADGRB2	1376	O60241
RSGARLVPSDKFSPR	CEP170	1186	Q5SW79
PSPRARASRLAGEKS	SLC4A3	206	P48751
RLRSTPSSKLEGQGP	ARHGEF40	741	Q8TER5
SDISFPKRGPLSRTN	ANKRD34C	286	P0C6C1
RQDPPSSRDSVGLRK	AMZ1	451	Q400G9
PSRRGRTIPDKIGST	BIRC6	3936	Q9NR09
RTFGERSVSRLPSKP	BUB1	551	O43683
ASLLFRRTKATAPGP	BCAR1	601	P56945
RSTLGKLFRRPTPAS	CARMIL2	121	Q6F5E8
PGAAPRTRKTTFGDL	CARMIL2	1121	Q6F5E8
RTRKTTFGDLLRPPT	CARMIL2	1126	Q6F5E8
EPAKGLRSRPARAAA	BHLHA15	36	Q7RTS1
RRSEGPSLSPSGKRL	C17orf100	46	A8MU93
SRGKPALSRVPFLEG	BRPF3	1036	Q9ULD4
RTVSFEQPPGLKATR	ANKRD36B	491	Q8N2N9
KRRALPSVAGLFTQP	DOT1L	1106	Q8TEK3
PPAAQESSRRRSRKG	RAD54L2	1261	Q9Y4B4
VLAQPSTSRKRPREG	CHEK2	511	O96017
FGLKQRPTPSRDAVV	BMP2	61	P12643
RLGRKTPPTLFRGSS	ATP8A2	1136	Q9NTI2
GVSVRSLEKRFPGSP	ABCA7	806	Q8IZY2
RDPREKPGLSSFRST	CCDC27	16	Q2M243
LKTLGARVTRRPFTP	CCDC60	121	Q8IWA6
VKRPRLARATSGPAA	GMEB2	356	Q9UKD1
SAGPRAPSELRALQK	NDST3	726	O95803
RLEPRFPQASKTSIG	RC3H2	226	Q9HBD1
TSFFRRAPQGKPRSG	RASSF3	21	Q86WH2
VKSQLPQRTPGTRER	INSYN1	171	Q2T9L4
RLTEFRKGAQSLPGP	IRX6	281	P78412
RLQRSRAKGTPTPAL	RADIL	186	Q96JH8
RRVSKLASGPLAAPA	ARHGEF17	56	Q96PE2
GRTEKRLPVSPSGRT	ANK2	1931	Q01484
RPESFRIDPKTGNIT	PCDH20	791	Q8N6Y1
PNIRTAPLGRSEKRT	MIR7-3HG	41	Q8N6C7
VSTPGPSRKRRRLSN	PBRM1	26	Q86U86
RPRKASSAPSQGKER	MICAL3	1631	Q7RTP6
QEPLKVTPRSREAFG	MAP1A	686	P78559
RPKLFVTPPEGSSRR	MAP7	271	Q14244
SQTESSLPGRRKERP	MAPK8IP3	191	Q9UPT6
SLPGRRKERPTSLNV	MAPK8IP3	196	Q9UPT6
PRLRSPGSKGAESRL	JMY	126	Q8N9B5
PGSKGAESRLRSPVR	JMY	131	Q8N9B5
ERLKAGASPRSVPAR	JSRP1	81	Q96MG2
RAPLGTRPLDVSSFK	MYCNOS	81	P40205
RKSRDSPFVPIGIAG	HIGD1C	21	A8MV81
KDRRVGTPSQGPFLR	WWC1	906	Q8IX03
PAATLARRDSLQKPG	LATS2	371	Q9NRM7
PEAETRGAKRISPAR	MUC20	76	Q8N307
GDSARRTLQPRLKPS	NAB2	16	Q15742
GEIDPLNRRFSTVPK	PHKA1	421	P46020
LIPSIVDRAPKGRTF	ASAH2	641	Q9NR71
ESFRSGAKPPLRARD	EDEM3	566	Q9BZQ6
VFKTPGLRTPAAGER	CDCA8	196	Q53HL2
KEGTLFPERTLPARN	CARMIL3	1251	Q8ND23
AGSTRNKDPTRRPEL	EFNB2	171	P52799
RLRSEQFPSKVGGRP	PDCD2	21	Q16342
GKTRNGFPLPLAREV	LPO	181	P22079
GPNTIASSRIEKPRA	FAM205A	216	Q6ZU69
SISPEARRKRNPLGS	FAM217B	51	Q9NTX9
PPGLQRSKSDLSERF	FAM110A	181	Q9BQ89
RRRSLPGLASSVKEP	DDX28	521	Q9NUL7
SALGQSLKPEPFGRR	LIPC	21	P11150
DPTSGPRLITRRKNL	LMO7	476	Q8WWI1
RKRRNSRDGDPLPSS	MVD	91	P53602
LQPKPRSGAVEETFR	HSDL2	301	Q6YN16
TRAKTRRFPGPAGIL	HROB	391	Q8N3J3
DGSNRTVIARVPKPR	LRP2	2496	P98164
QRVAPRARGKSSEPV	MKI67	3031	P46013
PSSLTPRLRSNDRKG	PSRC1	141	Q6PGN9
PAAAPIKTRTRRNKG	GGN	516	Q86UU5
PRPAVRKSAGQTLFS	MON2	1036	Q7Z3U7
KPSTIRRDAPAGRKV	RPL8	221	P62917
SFLRTSVPRGPKVGS	GOLGA3	211	Q08378
SPSALGKGVLSRRPE	IQSEC3	171	Q9UPP2
SPAKPAGAELRRAFL	INSM2	111	Q96T92
SQSFALRARRKGPPP	CASKIN2	856	Q8WXE0
KEGATGPRRRTLSEP	CASKIN2	896	Q8WXE0
VPGPRRTISKLRNET	PTPRU	536	Q92729
REPRGSRPLSSFVQK	POM121C	71	A8CG34
DSPLEKNPRSAGRIR	PLPPR2	311	Q96GM1
GSLGKRPSAPFRSNV	GPRC5B	361	Q9NZH0
TAQPEKGVDTFLRRP	PALB2	226	Q86YC2
PKRTNRPGISTTDRG	PABPN1	246	Q86U42
PRTPVGSRKASRNIF	PIKFYVE	251	Q9Y2I7
LAAAVSKGAPFRRPL	ATP13A2	1061	Q9NQ11
GISPKRRRLSSSLNP	ATR	426	Q13535
RKDGRLPSLSRSPLS	FBXL19-AS1	11	Q494R0
PSGQRSRSPLLKFVE	CCDC149	306	Q6ZUS6
TPGSLGDPVLKRRER	E2F7	876	Q96AV8
SLLPAPERQGAKSRT	E2F8	581	A0AVK6
NSLGRAPSLKRRSPS	CACNA1G	1111	O43497
GGRMTAPKTPRFLTR	LINC00304	66	Q8N9R0
GAPLTPNSRKRRESA	DMAP1	441	Q9NPF5
ARSKNDQLRISFPPG	CHD3	11	Q12873
SRARVPSRAAPGKSE	FNDC1	1146	Q4ZHG4
TLGRGEPSIPSNRIK	CNTN1	686	Q12860
RGKAPALSPSRELSF	GDF5-AS1	231	Q5U4N7
SLRKTRQPPERIASG	ABL1	1011	P00519
KARGSLIPRRATEPS	AKNA	971	Q7Z591
DSISRGRRSPSKPDF	BTBD7	1111	Q9P203
AGVKSQRPFSPREAL	LUZP1	736	Q86V48
LTPTTVGGPRKASFR	MARCHF10	256	Q8NA82
AGRPRPTTNLFTKLT	MARK4	606	Q96L34
DRPTLAAFSPVTKGR	MAPKBP1	1306	O60336
APRSVGSIKINFTPR	DNAAF4	231	Q8WXU2
PAKARRGPLRATSQD	FOXS1	126	O43638
RSSLKAPPQRSARGG	KHDRBS2	326	Q5VWX1
KDQSPSRAPGLRQRA	HMOX1	226	P09601
RGIRNFPTPGSAKSL	BEND7	496	Q8N7W2
LVDKFPAPSVRGSRL	CPEB1	156	Q9BZB8
ASEFPVPRVGSRKLL	HELZ2	2251	Q9BYK8
SSPLLDIVGGRKARP	AZU1	21	P20160
RASGRLPVATIAPNK	C4orf54	1196	D6RIA3
GSPRSKRALENLLPT	EDN1	86	P05305
PSKRRRVENSIPAAG	SART3	641	Q15020
VRTPSLKDSPAGRGL	INAVA	566	Q3KP66
RKLSFLPTPRTQGSE	PPRC1	1141	Q5VV67
ETALITRPGAPSRRK	DDAH1	86	O94760
EVRRKRIPSQPGSFS	MYBL1	281	P10243
LTFPRKRTPRVDGQT	MICAL2	656	O94851
RQSRERSPPVGRKAS	PCARE	981	A6NGG8
RKVRATLLPEAGRSP	PRR15	101	Q8IV56
RSQGTLSDLLRNPKP	ONECUT3	351	O60422
SRKVPLPFGVRNIST	RP1	71	P56715
GLTRRAPVKDTPGRA	RPH3AL	286	Q9UNE2
RPSRIPERFSGSKSG	IGLV3-32	71	A0A0A0MS00
GIRTPPVRRNSKLAT	PHACTR3	56	Q96KR7
SPPRRVTSFAELAKG	RUSC2	536	Q8N2Y8
TLETKRPQASRPLGA	SFI1	971	A8K8P3
EQTLLSPSEKPRRFG	TRIM41	566	Q8WV44
DTTVPRRLGPKRASR	RPS6	126	P62753
PGVSNIRTLDTPFRK	SPAG8	421	Q99932
GERRSRSPRKPIDSL	SRRM2	2671	Q9UQ35
FPKARRPESALLGGS	VGF	276	O15240
FQGLRTPQLTPGRKT	SPATA31C2	971	B4DYI2
RQAELKSGPASRPAL	SH3D21	446	A4FU49
RVPSKAAGSTRQPIR	SVIL	351	O95425
RKVRTRSLSDFTGPP	SVIL	541	O95425
KRKLSGDQPAARTPR	TCOF1	1346	Q13428
TRLARGSGPREKTPA	TOGARAM2	276	Q6ZUX3
LRSSPLAPVSGEKRR	LMF2	661	Q9BU23
TLPAKPRLQRGGSSA	SLC24A2	321	Q9UI40
TKDPRGTSAGRRPEL	ABCC6	871	O95255
GKEARLARSSPEQPR	PML	496	P29590
LPLIRERVPGASSFK	PML	711	P29590
DVASPTLRRLFGGKP	NAV2	1316	Q8IVL1
RFPPSLSETNKGLRG	PRRC2C	266	Q9Y520
PGFISIVKLESPRRA	RNF43	101	Q68DV7
SKVLPAFRESPSGRL	SIPA1L1	1246	O43166
GAETPRPLFQTKLSR	SHROOM1	331	Q2M3G4
SPVAAARKGSPRLLG	PTGES2	46	Q9H7Z7
STKSRAEGRAPNPAR	STK11	401	Q15831
KQRTGSFGDRPARPT	RFXAP	211	O00287
LDGAARPKGSRRSVP	SP6	206	Q3SY56
LATGQPATSRLPKAR	PRR12	1771	Q9ULL5
EKRRSTSRQFVDGPP	RACGAP1	181	Q9H0H5
ISLDKVQRSLGPRAP	SERTAD3	36	Q9UJW9
GGDLKSFLRETRPRP	ALK	1201	Q9UM73
ARASQVKPGDSLPRR	ADRA2A	336	P08913
GASPELAKSPRLRNA	AFAP1L1	96	Q8TED9
GPFRRPTTQLRAKVS	ADRA1D	501	P25100
GLALQPSFPGSRKLR	ACSM1	241	Q08AH1
ASELKRAGPRRRASP	CHSY1	31	Q86X52
TPKLRRLQFSSGEQP	C12orf54	91	Q6X4T0
QGVKVRPPLASFRDS	CLCN2	846	P51788
LDPRPGVVTKGFRTL	TRAK1	601	Q9UPV9
APSQEAGTKARFPLR	TGM2	66	P21980
KSPRSPQLSDFGLER	SKA3	151	Q8IX90
RKPSVGSPSLTRREF	TULP4	571	Q9NRJ4
QFRPRTGKAASTPLL	PSMD3	146	O43242
PKGAAAPSASQRRKR	MIXL1	76	Q9H2W2
VGSRNPKRTARLFPS	STEAP3	56	Q658P3
SPQVLPSSKRRRVEG	STAG3	1066	Q9UJ98
FSALSRGDPLPVKDR	ROPN1L	46	Q96C74
RVRPTSRQPSKDLGY	SLITRK5	341	O94991
EPGFSLKRPRGLSRS	PKMYT1	36	Q99640
AGQSRSSPLLKRPVR	RMC1	436	Q96DM3
PAPAKDALRALTQRG	PLPPR3	296	Q6T4P5
RSSRRGIINPFPASK	KIF21A	1316	Q7Z4S6
SPRRSPGAIKRNLSS	SGIP1	156	Q9BQI5
RSPRPKGDFSSRARE	STX18	41	Q9P2W9
VRLPRVGLAAPSKAS	PRX	1376	Q9BXM0
RFPRVSLSPKARSGS	PRX	1411	Q9BXM0
RNPLLSTSRPLVFGK	TBC1D8	941	O95759
LQVPSVFKPTRDDRG	SLC4A10	786	Q6U841
PTKPRRGSFEVTLLR	SELENOH	71	Q8IZQ5
LLTKRVAAPQDGSPR	SRA1	36	Q9HD15
PQRSAVITSLDPGRK	TNXB	1111	P22105
EKLPLSNRRPAAVGA	USP17L21	66	D6R901
PLKSEQFLAPVGRSR	TTLL3	661	Q9Y4R7
RAPGTPRDSIQLAKR	PLEKHH1	316	Q9ULM0
SSPRRRKPREAAGLT	nan	191	Q6ZRN7
ESLAANSRGREKPRP	ZNF839	506	A8K0R7
RGRPKTRSLGLAPTE	ZNF469	921	Q96JG9
EKLPLSNRRPAAVGA	USP17L12	66	C9JPN9
PPGAKRRRLSESSAL	WRNIP1	66	Q96S55
IRKREPGGRLPTSST	UBE3B	1021	Q7Z3V4
GSFPTRLTLKEQPRQ	TRIM10	416	Q9UDY6
ISEGDPRQSRPFKSV	SH3RF2	471	Q8TEC5
REILSPLFPRNGTKS	TASOR2	671	Q5VWN6
FSGKAEPRPRSSRLS	WNK4	46	Q96J92
NRDTLINPKGSFPAR	TRPM4	196	Q8TD43
APLTSIRGRKPLFGE	ZFYVE16	1206	Q7Z3T8
PRRGTQPVGSLELKS	TTF2	496	Q9UNY4
AKRPNTSPDRGSRDR	ZC3H18	846	Q86VM9
LEKQVFGSRSLPRGP	MXRA5	1576	Q9NR99
RTRSKALRGPPETTA	MYT1	11	Q01538